Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies
Half the epidemiological studies with information about menopausal hormone therapy and ovarian cancer risk remain unpublished, and some retrospective studies could have been biased by selective participation or recall. We aimed to assess with minimal bias the effects of hormone therapy on ovarian cancer risk.